- Home
- TC vs SXTP Comparison
TC vs SXTP Comparison
Compare TC & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- SXTP
- Stock Information
- Founded
- TC 2010
- SXTP 2010
- Country
- TC China
- SXTP United States
- Employees
- TC N/A
- SXTP N/A
- Industry
- TC Business Services
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- TC Consumer Discretionary
- SXTP Health Care
- Exchange
- TC Nasdaq
- SXTP Nasdaq
- Market Cap
- TC 2.6M
- SXTP 2.4M
- IPO Year
- TC 2018
- SXTP 2023
- Fundamental
- Price
- TC $0.84
- SXTP $0.45
- Analyst Decision
- TC
- SXTP Hold
- Analyst Count
- TC 0
- SXTP 1
- Target Price
- TC N/A
- SXTP N/A
- AVG Volume (30 Days)
- TC 2.0M
- SXTP 5.8M
- Earning Date
- TC 03-27-2025
- SXTP 03-31-2025
- Dividend Yield
- TC N/A
- SXTP N/A
- EPS Growth
- TC N/A
- SXTP N/A
- EPS
- TC N/A
- SXTP N/A
- Revenue
- TC $14,107,804.00
- SXTP $462,612.00
- Revenue This Year
- TC N/A
- SXTP $141.35
- Revenue Next Year
- TC N/A
- SXTP $175.16
- P/E Ratio
- TC N/A
- SXTP N/A
- Revenue Growth
- TC N/A
- SXTP 128.99
- 52 Week Low
- TC $0.75
- SXTP $0.41
- 52 Week High
- TC $4.30
- SXTP $7.20
- Technical
- Relative Strength Index (RSI)
- TC 41.42
- SXTP 33.01
- Support Level
- TC $0.78
- SXTP $0.47
- Resistance Level
- TC $1.10
- SXTP $0.67
- Average True Range (ATR)
- TC 0.06
- SXTP 0.10
- MACD
- TC -0.01
- SXTP 0.00
- Stochastic Oscillator
- TC 18.13
- SXTP 12.96
About TC TuanChe Limited
TuanChe Ltd is an omnichannel automotive marketplace in China. The company operates in one operating segment of providing auto shows, special promotion events services, and virtual dealership, online marketing services, and others. It organizes auto shows, for the purpose of facilitating transactions between consumers and auto dealers that include auto dealers, automakers, and automotive service providers. It provides services through its online platform and offline events.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.